Format

Send to

Choose Destination
J Clin Lab Anal. 2000;14(2):83-6.

Clinical utility of a competitive ELISA to detect antibodies against Treponema pallidum.

Author information

1
Department of Microbiology, Clínico San Cecilio, University of Granada Hospital, Granada, Spain. josegf@goliat.ugr.es

Abstract

Screening for Treponema pallidum infection is carried out on a large human population. To reduce costs, fewer tests which still offer adequate sensitivity and specificity could be performed. We studied the reliability of a novel indirect ELISA method to test for this infection. Several panels of sera were used that corresponded to 40 primary infections (group 1), 13 recurrences (group 2), 348 latent infections (group 3), 5 samples with anticardiolipin antibodies (group 4), 15 samples from patients with Lyme borreliosis (group 5), and 400 samples from blood donors and healthy pregnant women (group 6). The ELISA showed a global sensitivity and specificity of 100 and 99.5%, respectively. Our evaluation shows that Enzygnost Syphilis is a sensitive, specific, and simple test to screen for this infection.

PMID:
10683619
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center